On September 1, 2020, the UK’s medicines and medical devices regulator released the MHRA post-transition information, an extensive suite of guidance on the UK regulatory regime post the Transition Period expiring on December 31, 2020. The new guidance spreads out across dozens of documents covering the following topics: Clinical trialsDevicesLicensingImporting…
